ChemicalBook > CAS DataBase List > Tofacitinib Impurity 19
Tofacitinib Impurity 19
- Product Name
- Tofacitinib Impurity 19
- CAS No.
- 2056104-91-5
- Chemical Name
- Tofacitinib Impurity 19
- Synonyms
- Tofatinib Impurity 19;Tofacitinib Impurity 133;N-((3S,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity);7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3S,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7-[(4-methylphenyl)sulfonyl]-
- CBNumber
- CB34842524
- Molecular Formula
- C27H31N5O2S
- Formula Weight
- 489.63
- MOL File
- 2056104-91-5.mol
More
Less
Tofacitinib Impurity 19 Property
- Boiling point:
- 655.2±65.0 °C(Predicted)
- Density
- 1.27±0.1 g/cm3(Predicted)
- pka
- 9.02±0.10(Predicted)
Tofacitinib Impurity 19 Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Tofacitinib Impurity 19 Suppliers
- Tel
- 15374522761
- Fax
- QQ:2853117752
- 3003392093@qq.com
- Country
- China
- ProdList
- 8377
- Advantage
- 55
- Tel
- 020-36607679 17825480238
- Fax
- QQ 3008233717
- 3008233717@qq.com
- Country
- China
- ProdList
- 9919
- Advantage
- 12
- Tel
- 86-714-3992388
- overseasales1@yongstandards.com
- Country
- United States
- ProdList
- 14332
- Advantage
- 58
- Tel
- 2710913286@.com
- 1513643261@qq.com
- Country
- China
- ProdList
- 14246
- Advantage
- 58
- Tel
- 0755-66853366; 13670046396
- ORDERS@QCSRM.COM
- Country
- China
- ProdList
- 24326
- Advantage
- 58
- Tel
- 18627756402
- 3001051413@qq.com
- Country
- China
- ProdList
- 9544
- Advantage
- 58
- Tel
- 2122619822
- czbjpharma@126.com
- Country
- China
- ProdList
- 18478
- Advantage
- 58
- Tel
- 400-400-8210725
- malulu@leyan.com
- Country
- China
- ProdList
- 39990
- Advantage
- 58
- Tel
- 18502726233; 18502726233
- 3641133981@qq.com
- Country
- China
- ProdList
- 9705
- Advantage
- 58
- Tel
- 18672472998
- sunchenjie@hdimpurity.com
- Country
- China
- ProdList
- 6697
- Advantage
- 58
2056104-91-5, Tofacitinib Impurity 19Related Search:
4-(Hydroxyamino)-4-oxobutanoic acid
CYANOACETIC ACID-OSU
N-Hydroxysuccinimide
Tofacitinib Impurity 2
Ethyl S-4-chloro-3-hydroxybutyrate
2-amino-4-fluoro-5-nitrobenzoic acid
TF-A
(3R,4R)-N,4-dimethyl-piperidin-3-amine
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile
(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine
Tofacitinib Impurity 20
R-afatinib
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine